NCT02388776

Brief Summary

This is an interventional pilot study of 40 burn inpatients. Specific aims of the proposed pilot study are to use bedside blood analysis with rotational thromboelastometry (ROTEM) in severe burn patients to provide preliminary information on the nature of coagulation abnormalities and compare subject ROTEM coagulation profiles within 24 hours of burn injury (day 1) and on days 2, 3, 5, 7, 14 and 21 after burn injury.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2015

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2015

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

February 2, 2015

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 17, 2015

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2016

Completed
1.9 years until next milestone

Results Posted

Study results publicly available

April 19, 2018

Completed
Last Updated

July 5, 2018

Status Verified

June 1, 2018

Enrollment Period

1.4 years

First QC Date

February 2, 2015

Results QC Date

October 25, 2017

Last Update Submit

June 5, 2018

Conditions

Keywords

ROTEMFibrinogen

Outcome Measures

Primary Outcomes (1)

  • Coagulation Parameters

    To compare ROTEM coagulation parameters involving fibrin contribution to clot formation (FIBTEM) between patients on admission/enrollment (day 1), and on days 2, 3, 5, 7, 14 and 21 after burn injury to see if expected hypercoagulability shows evidence of resolution.

    21 days

Secondary Outcomes (1)

  • Predictive Value of ROTEM Data

    21 days

Study Arms (1)

ROTEM

EXPERIMENTAL

Clinical burn ICU Inpatients receiving blood draws for ROTEM analysis and fibrinogen levels.

Device: ROTEM

Interventions

ROTEMDEVICE

A blood sample and reagents are placed into a small cup. A pin suspended from a wire is immersed into the sample. The pin rotates back and forth at a fixed angle. The movement of the pin is optically monitored and converted into a real time measurement that is represented graphically. Prior to clot formation, pin rotation is unhindered and is graphically represented as a straight line. As the subject's blood sample starts to clot, strands of clot form between the pin and the cup wall, restricting the movement of the pin depending on the strength of the clot. Graphically, this is represented as a symmetrical widening of the curve.

Also known as: ROTEM delta
ROTEM

Eligibility Criteria

Age3 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Consecutive patients admitted to NYPH with 15% TBSA burn or greater.
  • Patients with vascular access catheters (arterial or central line) placed within 24 hours of burn injury
  • Males and females
  • Ages \>3 years or \>15 kg
  • Informed verbal consent obtained from the patient or the patient's designated health care proxy (DHCP). In the case of minors, assent and informed verbal consent obtained from at least one parent or guardian.

You may not qualify if:

  • Known pre-existing hemostatic abnormalities
  • Ages \< 3 years or weight \< 15 kg
  • Intake of anticoagulants or antiplatelet aggregation inhibitors prior to burn
  • Pregnant patients
  • Patients with delayed presentation (greater than 24 hours after burn injury)
  • Refusal or inability of patient or patient's DHCP to consent in English.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Weill Cornell Medical College

New York, New York, 10065, United States

Location

MeSH Terms

Conditions

Burns

Condition Hierarchy (Ancestors)

Wounds and Injuries

Limitations and Caveats

Early termination leading to small numbers of subjects analyzed. Small numbers of subjects due to the critical condition of subject population.

Results Point of Contact

Title
Christine Lennon, M.D.
Organization
Weill Cornell Medicine

Study Officials

  • Christine Lennon, MD

    Weill Medical College of Cornell University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 2, 2015

First Posted

March 17, 2015

Study Start

January 1, 2015

Primary Completion

June 1, 2016

Study Completion

June 1, 2016

Last Updated

July 5, 2018

Results First Posted

April 19, 2018

Record last verified: 2018-06

Data Sharing

IPD Sharing
Will not share

There is no plan to share IPD

Locations